Sivasubramanian Baskar

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.

Sivasubramanian Baskar, Suzanne Ostrand‐Rosenberg, N Nabavi et al. · Proceedings of the National Academy of Sciences · 1993 · 268 citations · Full text

Histocompatibility, Resident Tumor Cells, T-regulatory Cell +19

The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

Michael Hudecek, Thomas M. Schmitt, Sivasubramanian Baskar et al. · Blood · 2010 · 264 citations · Full text

Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia

Sivasubramanian Baskar, Ka Yin Kwong, Thomas Höfer et al. · Clinical Cancer Research · 2008 · 240 citations · Full text

A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease

Davide Bagnara, Matthew Kaufman, Carlo Calissano et al. · Blood · 2011 · 217 citations

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.

Sivasubramanian Baskar, Laurie H. Glimcher, N Nabavi et al. · The Journal of Experimental Medicine · 1995 · 185 citations · Full text

Histocompatibility, Class Ii, Immunology +17